Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 1997

View Archived Issues

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

ET antagonists disclosed by Merck KGaA

Microcide reveals new cephalosporins active against resistant organisms

Opioid antagonists/agonists described by Toray

Banyu discovers potent new antitumor agent

Natural antitumor compounds described by Banyu

Inhibitors of 5alpha-reductase from Kyowa Hakko

Antiviral pyrimidine nucleosides described by Yamasa

Prodrugs of nitrogen mustard with selective antitumor activity

MP-52 to be developed worldwide by HMR

NDA to be submitted in Japan for nevirapine

Glaxo to submit NDA in Japan for lamivudine in hepatitis

Tamsulosin cleared by FDA

Protease inhibitors in Japan

PharmaSciences and BTG extend license for hydrogel drug delivery technology

Fujisawa and Solvay sign marketing agreement for antidepressant

IDEC Pharmaceuticals: Q1 1997 highlights

Novel antiinflammatory agent from Parke-Davis

Sano: Q1 1997 highlights

Neutralase effective for heparin reversal in CAB

GalaGen: Q1 1997 highlights

OXiGENE: Q1 1997 highlights

Algos: Q1 1997 highlights

BY-963 for delineation of myocardial perfusion during cardiac surgery

Clevidipine for controlling hypertension after CABG

Favorable hemodynamic profile of aptiganel during general anesthesia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...